Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (Q42923039)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 August 2010

Language	Label	Description	Also known as
English	Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).	scientific article published on 29 August 2010

Statements

scholarly article

1 reference

Europe PubMed Central

11 November 2017

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (English)

1 reference

Europe PubMed Central

11 November 2017

atrial fibrillation

0 references

Paulus Kirchhof

4

1 reference

Europe PubMed Central

11 November 2017

17

1 reference

Europe PubMed Central

11 November 2017

27

object named as

Frans H Rutten

1 reference

Europe PubMed Central

11 November 2017

Piotr Ponikowski

object named as

Piotr Ponikowski

26

0 references

5

object named as

Gregory Y H Lip

1 reference

Europe PubMed Central

11 November 2017

16

object named as

Dan Atar

1 reference

Europe PubMed Central

11 November 2017

Gerhard Hindricks

11

object named as

Gerhard Hindricks

1 reference

Europe PubMed Central

11 November 2017

European Heart Rhythm Association

1

object named as

European Heart Rhythm Association

1 reference

Europe PubMed Central

11 November 2017

Isabelle C Van Gelder

9

object named as

Isabelle C Van Gelder

1 reference

Europe PubMed Central

11 November 2017

24

object named as

Philippe Kolh

1 reference

Europe PubMed Central

11 November 2017

20

object named as

Andreas Goette

1 reference

Europe PubMed Central

11 November 2017

Hein Heidbuchel

13

object named as

Hein Heidbuchel

1 reference

Europe PubMed Central

11 November 2017

Ulrich Schotten

6

object named as

Ulrich Schotten

1 reference

Europe PubMed Central

11 November 2017

21

object named as

Bulent Gorenek

1 reference

Europe PubMed Central

11 November 2017

Jean-Yves Le Heuzey

25

object named as

Jean-Yves Le Heuzey

1 reference

Europe PubMed Central

11 November 2017

Raffaele De Caterina

18

object named as

Raffaele De Caterina

1 reference

Europe PubMed Central

11 November 2017

3

object named as

A John Camm

1 reference

Europe PubMed Central

11 November 2017

Nawwar Al-Attar

10

object named as

Nawwar Al-Attar

1 reference

Europe PubMed Central

11 November 2017

Irene Savelieva

7

object named as

Irene Savelieva

1 reference

Europe PubMed Central

11 November 2017

8

object named as

Sabine Ernst

1 reference

Europe PubMed Central

11 November 2017

Bernard D Prendergast

12

object named as

Bernard Prendergast

1 reference

Europe PubMed Central

11 November 2017

Ottavio Alfieri

14

object named as

Ottavio Alfieri

1 reference

Europe PubMed Central

11 November 2017

22

object named as

Magnus Heldal

1 reference

Europe PubMed Central

11 November 2017

Stefan H. Hohloser

23

object named as

Stefan H Hohloser

1 reference

Europe PubMed Central

11 November 2017

Johan De Sutter

19

object named as

Johan De Sutter

1 reference

Europe PubMed Central

11 November 2017

author name string

European Association for Cardio-Thoracic Surgery

2

1 reference

Europe PubMed Central

11 November 2017

Annalisa Angelini

15

1 reference

Europe PubMed Central

11 November 2017

publication date

29 August 2010

1 reference

Europe PubMed Central

11 November 2017

European Heart Journal

1 reference

Europe PubMed Central

11 November 2017

31

1 reference

Europe PubMed Central

11 November 2017

2369-2429

1 reference

Europe PubMed Central

11 November 2017

19

1 reference

Europe PubMed Central

11 November 2017

Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Outcome parameters for trials in atrial fibrillation: executive summary

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Increasing prevalence of atrial fibrillation and flutter in the United States

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Effect of atrial fibrillation on atrial refractoriness in humans.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Histological substrate of atrial biopsies in patients with lone atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Sodium channel mutations and susceptibility to heart failure and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

KCNQ1 gain-of-function mutation in familial atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardi

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Comparison of continuous versus intermittent monitoring of atrial arrhythmias.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Indications for the use of diagnostic implantable and external ECG loop recorders

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Amiodarone versus sotalol for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Independent predictors of stroke in patients with atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Soc

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Rhythm control versus rate control for atrial fibrillation and heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Catheter ablation for atrial fibrillation in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Effect of dronedarone on cardiovascular events in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Lenient versus strict rate control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Use of medications in Wolff-Parkinson-White syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Evidence-based analysis of amiodarone efficacy and safety

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome--a case-control pilot study using i.v. sotalol

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Increased mortality after dronedarone therapy for severe heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Consensus document on antithrombotic therapy in the setting of electrophysiological procedures

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Successful surgical treatment of atrial fibrillation. Review and clinical update

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Surgical approaches to atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Valsartan for prevention of recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Statins and polyunsaturated fatty acids for treatment of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Usefulness of statins in preventing atrial fibrillation in patients with permanent pacemaker: a systematic review.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Cardiac resynchronization therapy in heart failure patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Dep

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Relation of vigorous exercise to risk of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Long-lasting sport practice and lone atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Management of atrial fibrillation in the post-cardiac surgery setting

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A multicenter risk index for atrial fibrillation after cardiac surgery

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

A Randomized Study of Prophylactic Catheter Ablation in Asymptomatic Patients with the Wolff–Parkinson–White Syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Giant T–U Waves Precede Torsades de Pointes in Long QT Syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablatio

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ278

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHQ278

1 reference

Europe PubMed Central

11 November 2017

release_ivt52khpgzh47d4qmbfwyd45qi

1 reference

https://api.fatcat.wiki/v0/release/ivt52khpgzh47d4qmbfwyd45qi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42923039&oldid=1838654154"